Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Boston Scientific's heart failure lead:

This article was originally published in Clinica

Executive Summary

The Acuity Steerable left ventricular lead developed by Boston Scientific has gained Japanese approval, and may now be used with cardiac resynchronisation therapy (CRT) devices. The lead has a deflectable tip to aid placement in difficult-to-access branch vessels on the left side of the heart. It also provides physicians with four configurations for stimulating the left side of the heart, Boston said, which allows physicians to change the stimulation site noninvasively after implantation. The lead also received reimbursement approval from the Japanese National Health Insurance System. Natick, Massachusetts-based Boston plans to launch the product immediately in Japan.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT046763

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel